ClinicalTrialsFinder

Portal Vein Tumor Thrombus Clinical Trials in Shenyang, Liaoning

1 recruitingShenyang, Liaoning, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus

Hepatocellular Carcinoma (HCC)Portal Vein Tumor Thrombus
First Hospital of China Medical University38 enrolled1 locationNCT07483359